Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Healthcare
Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:GUD)

Knight to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

GlobeNewswire April 9, 2024

Knight Therapeutics Inc. ranks on The Globe and Mail's fifth-annual Women Lead Here benchmark of executive gender diversity

GlobeNewswire March 28, 2024

Knight Therapeutics Reports Fourth Quarter and Year-End 2023 Results

GlobeNewswire March 21, 2024

Notice of Knight Therapeutics' Fourth Quarter and Year End 2023 Results Conference Call

GlobeNewswire March 14, 2024

Knight Therapeutics Announces Launch of Minjuvi® in Brazil

GlobeNewswire February 29, 2024

Knight Therapeutics Inc. Celebrates its First Decade of Success

GlobeNewswire February 28, 2024

Knight Therapeutics Announces Regulatory Submission of Fostamatinib in Brazil

GlobeNewswire February 21, 2024

Knight Therapeutics Announces Launch of Bijuva® in Canada

GlobeNewswire February 6, 2024

Knight Therapeutics Enters into Exclusive License Agreement with Amneal Pharmaceuticals for IPX203

GlobeNewswire January 25, 2024
View More News ››

Opinion & Analysis (TSX:GUD)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:GUD)

RE:RE:Antibe

What is 6% of zero? hm...
Chianchin - 2 days ago

RE:RE:RE:Antibe

GUD also has one seat on the board - I believe. Goodman vacated the board to make the initial deal. Then Samira was put on the board...
MrMugsy - 5 days ago

RE:Antibe

Knight owns ~6% of global geographies for sales of any and all ATE drugs. Canada Russia Sub-Saharan Africa Israel
MrMugsy - 5 days ago

GUD Motley fool article April 16, GUD shares +40%

https://www.fool.ca/2024/04/16/tsx-healthcare-in-april-2024-the-best-stocks-to-buy-right-now/   ***** Positioned for future...
GoldenInvestor - 7 days ago

GUD summary

Celebrating 10 years just past   $343M revenues, cash flow & other(EBITDA) all record   Exelon expense now...
GoldenInvestor - 9 days ago

RE:RE:Antibe

Thank you, wonder if they still have it
NSMTL05 - April 11, 2024
View more Bullboard ››

International Lithium Corp.

International Lithium Corp.

International Lithium Corp has lithium exploration properties located in Canada and Ireland. Its primary strategic focus is ...
View More »